Alnair is a preclinical stage, platform precision oncology company focused on new methods to treat difficult-to-treat cancers. We developed a first-in-class drug delivery technology that leverages the unique features of cancer metabolism to enhance targeting and penetration of drugs directly to cancer cells, and to improve treatment outcomes for patients.
Company Details
- Employees
- 3
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Alnair Therapeutics Questions
Alnair Therapeutics's LinkedIn profile is https://www.linkedin.com/company/alnair-therapeutics
Alnair Therapeutics has
3 employees.
View email and phone details for 3
employees at Alnair Therapeutics.
Alnair Therapeutics's industry is
Biotechnology Research
Alnair Therapeutics's top competitors are
Grove Biopharma, Inc.,
Reax Biotechnologies,
Portal Innovations,
Saros Therapeutics,
Adipo Therapeutics,
Syntax Bio,
Circ Biosciences,
Dimension Bio,
Zylem Biosciences,
Addgraft Therapeutics.
Alnair Therapeutics's categories are Biotechnology Research
